JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present a protocol to establish high-performance liquid chromatography (HPLC), coupled with chemical fingerprint multi-pattern recognition, which provides a new strategy for effectively identifying the genuine varieties of Clematidis Armandii Caulis and its adulterants.

Abstract

A method for identifying Chinese medicinal materials and their related adulterants was constructed by taking Clematidis Armandii Caulis (Chuanmutong, a universally used traditional Chinese medicine) as an example. Ten batches of genuine Chuanmutong varieties and five batches of related adulterants were analyzed and compared based on the high-performance liquid chromatography (HPLC) fingerprints combined with chemometrics, including cluster analysis (CA), principal component analysis (PCA), and orthogonal partial least-squares discrimination analysis (OPLS-DA). In addition, the content of β-sitosterol was determined. The control chemical fingerprint of Chuanmutong was established, and 12 common peaks were identified. The similarity between the fingerprint of 10 batches of genuine Chuanmutong varieties and the control fingerprint was 0.910-0.989, while the similarity of five batches of adulterants was only 0.133-0.720. Based on the common peaks in the chromatogram, 15 batches of samples were classified into three content levels by PCA, and were aggregated into four categories by CA, achieving a clear distinction between authentic Chuanmutong and adulterants of Chuanmutong. Further, seven differential components that can effectively identify authentic Chuanmutong and adulterants of Chuanmutong were found through OPLS-DA. The β-sitosterol content of 10 batches of genuine Chuanmutong varieties was 97.53-161.56 µg/g, while the β-sitosterol content of the five batches of adulterants varied greatly, among which the β-sitosterol content of Clematis peterae Hand.-Mazz. and Clematis gouriana Roxb. Var. finetii Rehd. et Wils. was significantly lower than that of authentic varieties of Chuanmutong. The HPLC index component content and chemical fingerprint multi-pattern recognition method established in this study provide a new strategy for effectively identifying authentic Chinese medicinal materials and related adulterants.

Introduction

Chuanmutong, dry Caulis of Clematis armandii Franch. or Clematis montana Buch.-Ham., is a traditional Chinese medicine commonly used in clinics1,2,3. It is used for treating urinary problems, edema, sores on the tongue and mouth, decreased milk secretion, joint stiffness, and muscle pain caused by damp heat4. Chuanmutong has always been obtained from wild varieties, mainly distributed in southwest China, especially in Sichuan, where the best quality can be found5,6. It is difficult to distinguish between authentic varieties and their closely related adulterants due to their similar characteristics7,8,9,10. The quality standard of Chuanmutong in the 2020 edition of Chinese Pharmacopoeia only stipulates the properties, microscopic identification, and thin-layer identification without content determination, which cannot effectively identify adulterants, and hence has potential risks. Moreover, there are few reports comparing and identifying Chuanmutong and related plants. Consequently, a quality control method to ensure the authenticity of Chuanmutong is worthy of further study.

The chemical constituents of Chuanmutong are mainly composed of oleanane-type pentacyclic triterpenoids and their glycosides, flavonoids, and organic acids11,12,13,14. Among them, oleanolic acid, β-sitosterol, stigmasterol, and ergosterol have diuretic effects of different intensities, which may be potential pharmacodynamic substances for promoting diuresis and relieving stranguria15,16. Chemical fingerprints are obtained by separating and detecting many chemical components contained in samples by high-performance liquid chromatography (HPLC), gas chromatography (GC), etc. Adopting appropriate statistical analysis methods to analyze the characteristics of Chuanmutong can determine the overall quality control and scientific identification of traditional Chinese medicine17,18,19.

In this study, 10 batches of Chuanmutong authentic varieties and five batches of adulterants were collected. Their quality was compared and analyzed by the HPLC fingerprint method combined with multi-pattern recognition, including cluster analysis (CA), principal component analysis (PCA), orthogonal partial least-squares discrimination analysis (OPLS-CA), and content determination of the pharmacodynamic component. This protocol establishes a method for identifying authentic varieties with high specificity, a new strategy for the scientific identification of authentic varieties and adulterants of Chinese medicinal materials.

Protocol

1. Methods for chemical fingerprint detection

  1. Chromatographic conditions
    1. Prepare the acetonitrile (A)/water (B) mobile phase. Set a gradient program as follows in the HPLC software: 0-20 min, 3%A-10%A; 20-25 min, 10%A-13%A; 25-65 min, 13%A-25%A; 65-75 min, 25%A-40%A; 75-76 min, 40%A-3%A; 76-85 min, 3%A-3%A.
    2. Maintain the flow rate of the mobile phase at 1.0 mL/min.
    3. Conduct the chromatographic separation on a C18 column (250 mm x 4.6 mm, 5 µm) maintained at 30 °C.
    4. Set the injection volume to 10 µL.
    5. Detect the samples at a wavelength of 205 nm.
      NOTE: For the specific settings of chromatographic conditions, refer to the operating procedures of the working software of high-performance liquid chromatography (Table of Materials).
  2. Preparation of the sample solution
    1. Grind the raw materials to uniform particle size by passing them through a nylon mesh with an inner diameter of 850 µm ± 29 µm.
    2. Place 2 g of the ground raw material (accurately weighed) in a 50 mL conical flask with a stopper and add 50 mL of methanol. Place the stopper on the flask and ultrasonicate (600 W, 40 kHz) for 30 min.
    3. Then, cool the flask to room temperature (RT). Weigh the samples again, and make up for the initial weight by replacing the lost extractant.
    4. Pour 4 mL of the methanol solution containing the medicinal extracts into a 10 mL volumetric flask. Add 6 mL of H2O, mix, and allow it to settle for 10 min.
    5. Finally, filter the supernatant through a 0.45 µm filter membrane and place it on standby.
  3. Validation of fingerprint detection methods
    1. Prepare the sample as described above (step 1.2) and subject it to HPLC analysis (step 1.1) six times a day. To evaluate the precision, calculate the relative standard deviation (RSD) of relative retention time and relative peak areas as described in step 1.3.5.
    2. Evaluate the stability of the sample solution by analyzing the same sample solution stored at RT for 0, 2, 4, 6, 8, 12, and 24 h, and calculate the RSD of relative retention time and relative peak areas as described in step 1.3.5.
    3. Take six replicates of the same sample (CMT-4), prepare the sample solution according to the above procedure (step 1.2), and detect its fingerprint in HPLC following step 1.1. Calculate the RSD of relative retention time and relative peak areas, and evaluate its repeatability as described in step 1.3.5.
    4. Then use peak number 10 in Figure 1B as the reference peak and calculate the RSD of the relative retention time and relative peak area of each common peak as described in step 1.3.5.
    5. Use the formulas mentioned below to calculate the relative retention time and relative peak area of each common peak:
      Tre = Tcharacteristic/Treference
      Are = Acharacteristic/Areference

      Where Tre =relative retention time, Tcharacteristic = characteristic peak retention time, Treference = reference peak retention time, Are = relative peak area, Acharacteristic = characteristic peak area, and Areference = reference peak area.
      ​NOTE: The establishment of traditional Chinese medicine fingerprints generally requires selecting a chromatographic peak that is easy to obtain and has high resolution. This is used as a reference peak to identify the fingerprints and examine their stability and reproducibility.

2. Establishment of Chuanmutong fingerprint and similarity analysis

  1. Use 10 batches of authentic samples and five batches of adulterants such as Clematis argentilucida (Levl. et Vant.) W. T. Wang (CC), Clematis apiifolia var. obtusidentata Rehd. et Wils. (DC), Clematis peterae Hand.-Mazz. (DE), Clematis gouriana Roxb. Var. finetii Rehd. et Wils (XS), and Clematis finetiana Levl. et Vaniot. (SMT) as samples for fingerprint analysis.
  2. Prepare the sample solutions as described in step 1.2. Perform fingerprint analysis of all sample solutions by HPLC according to the conditions described under step 1.1.
  3. Import the relevant data into the similarity evaluation system of chromatographic fingerprints of traditional Chinese medicine (SESCF-TCM, 2012 version).The system will designate the peaks with reasonable height and good resolution in the chromatograms of all samples as common peaks.
    NOTE: The SESCF-TCM software can be downloaded after registration on the website of the Chinese Pharmacopoeia Commission (http://114.247.108.158:8888/login).
    1. In the software, click the Set Reference Spectrum button in the menu.
    2. Then in the Parameter Settings window, set the Time Window Width to 0.5 and select Control Spectrum Generation Method as the Median Method.
    3. Click on Multi-point Calibration in the main menu, then select Peak Matching as Full Spectrum Peak Matching.
    4. Finally, click on Generate Control to generate the reference chromatographic fingerprint of the authentic species of Chuanmutong.
  4. Import the retention time and peak area of 10 batches of authentic Chuanmutong samples and five batches of adulterants into SESCF-TCM for analysis. The specific operations are as follows:
    1. In the software, click on the Set Reference Spectrum button in the main menu.
    2. In the Parameter Settings window, set the reference chromatographic fingerprint of the authentic species of Chuanmutong as the reference, select the Control Spectrum Generation Method as the Median Method, and set the Time Window Width to 0.5.
    3. Click on Multi-point Calibration in the main menu, then select Peak Matching as Full Spectrum Peak Matching.
    4. Finally, click on Calculate Similarity to calculate the similarity based on the reference chromatogram fingerprints of Chuanmutong. Finally, calculate the similarity of fingerprints using the Chinese Medicine Chromatographic Fingerprint Evaluation System (2012 version).
      ​NOTE: For the specific operations, refer to the operating specifications for the Chinese Medicine Chromatographic Fingerprint Evaluation System (2012 version).

3. Multi-pattern recognition analysis of Chuanmutong fingerprint

  1. Cluster analysis (CA)
    1. Use the peak areas of 12 common peaks in the fingerprints of 10 batches of authentic Chuanmutong samples and their five batches of adulterants as variables, and input them into statistical analysis software for systematic cluster analysis (CA).
    2. Choose the Between-Groups method and use the Pearson correlation coefficient as the classification basis to draw a cluster analysis diagram of Chuanmutong and its adulterants. The specific operations are as follows:
      1. In the statistical analysis software, click on File to import data.
      2. Click on Analysis in the menu and then click on System Clustering in Classification.
      3. Select the common peak area as a variable, and set the number of clusters to four.
      4. Click on Method, select the clustering method as Inter-Group Connection, select the measurement interval as Pearson Correlation, and click on OK to draw the CA map.
  2. Principal component analysis (PCA)
    1. Import the relative common peak area of the authentic varieties and their adulterants into the analysis software for PCA analysis, and use the PCA score map to evaluate the score matrix map of sample differences. The specific operations are as follows:
      1. Open the data analysis software, click on File on the menu and create a new regular project. Import the peak area of 12 common peaks in a spreadsheet (e.g., excel format) from the HPLC system. Then click on Finish to complete the data import.
      2. Click on New to create a new model to set the model type with PCA. Click on Autofit and Add to fit the data, then click on Scores to get the PCA score map.
  3. Orthogonal partial least-squares discrimination analysis (OPLS-DA)
    1. Use the Orthogonal partial least-squares discrimination analysis method with supervision mode to further analyze the relative common peak area peaks of the authentic Chuanmutong varieties and adulterants and draw an OPLS-DA classification score map of all samples. The specific operations are as follows:
      1. In data analysis software, click on File in the menu to import a file and create a new regular project. Import the peak area of 12 common peaks in a spreadsheet from the HPLC system, then click on Finish to complete the data import.
      2. Click on New to create a new model to set the model type with PCA. Click on Autofit and Add to fit the data. Then click on Scores to get the PCA score map.
      3. Click on New and choose New as Model One to set the model type with OPLS-DA.
      4. Click on Scale and set type with Par for All. Click on Autofit first and then click on Scores to get the OPLS-DA score map.
    2. In order to determine the influence of each common peak in Chuanmutong on its classification results and the difference between authentic Chuanmutong materials and related adulterants, use the variable importance in the projection (VIP) for analysis.
    3. Draw the VIP map of the different components of Chuanmutong. Use the resulting VIP map to assess the impact of each variable on the classification and to screen out components that contribute significantly to the differences between groups. The specific operations are as follows:
      1. In the data analysis software, click on Analyse in the menu and click on Permutations, set the number of permutations to 200, and get the R2 and Q2 of the OPLS-DA score map.
      2. Click on VIP and choose VIP Predictive to get the VIP map.

4. Determination of β-sitosterol in Chuanmutong by HPLC

  1. Chromatographic conditions (refer to step 1.1)
    1. Prepare the mobile phase: methanol-water (97:3).
    2. Set the flow rate of the mobile phase to 1.0 mL/min.
    3. Conduct the chromatographic separation on a C18 column (250 mm x 4.6 mm, 5 µm) maintained at 30 °C.
    4. Set the injection volume to 10 µL.
    5. Detect the component at a wavelength of 204 nm.
  2. Preparation of the sample solution
    1. Prepare the stock standard solution of β-sitosterol (0.1 mg/mL) by dissolving an accurately weighed quantity of the corresponding reference standard in methanol.
    2. Grind the analysis sample of the raw material to uniform particle size by passing the sample through the nylon mesh with an inner diameter of 180 µm ± 7.6 µm.
    3. Place 2 g of the ground raw material (accurately weighed) in a round-bottomed flask and add 50 mL of chloroform to it.
    4. Connect the flask to a reflux condenser and heat it in a boiling water bath (moderate boiling) for 60 min. Filter the extraction solution with a 15-20 µm filter paper.
    5. Evaporate the filtrate to near dryness on a boiling water bath (moderate boiling) for about 10 min.
    6. Dissolve the residue and make up the volume to 5 mL using methanol. Finally, pass the supernatant through a 0.45 µm filter membrane, and place it on standby.
  3. Method validation
    1. Take the stock solution of β-sitosterol prepared in sub-step 4.2.1, dilute it with 100% methanol, and prepare solutions with 100 µg/mL, 80 µg/mL, 60 µg/mL, 50 µg/mL, 40 µg/mL, 30 µg/mL, and 20 µg/mL concentrations.
    2. Inject the samples under the chromatographic conditions described in step 4.1 to determine the peak area, perform regression analysis with the peak area to the injection volume, and obtain the regression equation and correlation coefficient to evaluate its linearity.
    3. Prepare the samples as described above (step 4.2) and subject them to HPLC analysis (step 4.1) six times on the same day. Then calculate the RSD of peak areas to evaluate the precision.
    4. Evaluate the stability of the sample solution by analyzing the same sample solutions stored at RT for 0, 2, 4, 6, 8, 12, and 24 h, as described in step 4.1. Then calculate the RSD of peak areas as described in step 1.3.5.
    5. Examine the repeatability by dissolving the same sample (CMT-4) in sextuplicate, prepared as described in step 4.2, and subjecting them to HPLC analysis as described in step 4.1. Then calculate the RSD of β-sitosterol content in six samples.
    6. Assess the method's accuracy by employing the standard addition method. For this, add β-sitosterol reference solutions to the samples at 80%, 100%, and 120% of the β-sitosterol content and repeat each condition three times as described in step 4.1. Evaluate the method's accuracy by calculating the average recovery and RSD.
      NOTE: The calculation formula of the rate of recovery (RR) is as follows:
      RR % = [(Mt - M0) / Ms] × 100
      Where Mt = the quality of β-sitosterol after adding the standard, M0 = the quality of the sample solution, and Ms = the quality of β-sitosterol added.
  4. Determination of β-sitosterol content of samples
    1. Take 10 batches of authentic Chinese medicinal materials and five batches of related adulterants to prepare sample solutions according to step 4.2.
    2. Then inject each sample solution and β-sitosterol reference solution to determine the peak area under the conditions described in step 4.1, and calculate the β-sitosterol content of each sample by using the external standard one-point method.

Results

Chromatographic fingerprint of Chuanmutong and similarity analysis (SA)
The RSD values of the relative retention time of precision, repeatability, and stability were below 0.46%, 1.65%, and 0.53%, respectively; the RSD values of the relative peak area were below 4.23%, 3.56%, and 3.96%, respectively. As shown in Figures 1A,B, there were 12 distinct common peaks (from peak 1 to peak 12) in the HPLC fingerprints in the 10 authentic Chuanmutong samples. S...

Discussion

The sample collection for research is the first key step to constructing multi-pattern recognition in identifying the authenticity of Chinese medicinal materials. Through market research, we found that Sichuan Ya'an, Liangshan, and Leshan are the main production areas of wild resources of Chuanmutong. The related varieties of the same genus also have the same geographical distribution6,20; CC, DC, DE, XS, and SMT are often misused as Chuangmutong

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by the Project of Sichuan Traditional Chinese Medicine Administration (no. 2020JC0088, no. 2021MS203).

Materials

NameCompanyCatalog NumberComments
Acetic acidZhiyuan Chemical Reagent Co., Ltd., Tianjin, China2017381038
AcetonitrileSigma-Aldrich  Trading Co., Ltd., Shanghai, ChinaWXBD5243V
β-SitosterolMeisai Biological Technology Co., Ltd., Chongqing, China20210201
 C18 columnYuexu Material Technology Co., Ltd., Shanghai, ChinaWelch Ultimate LP
ChuanmutongGuoqiang Chinese Herbal Pieces Co., Ltd., Sichuan, China 19020103CMT-1
ChuanmutongHongya Wawushan Pharmaceutical Co., Ltd., Sichuan, China 200701CMT-2
ChuanmutongHongpu Pharmaceutical Co., Ltd., Sichuan, China 200701CMT-3
ChuanmutongHongpu Pharmaceutical Co., Ltd., Sichuan, China 200901CMT-4
ChuanmutongXinrentai Pharmaceutical Co., Ltd., Sichuan, China 210701CMT-5
ChuanmutongHaobo Pharmaceutical Co., Ltd., Sichuan, China 210401CMT-6
ChuanmutongXinrentai Pharmaceutical Co., Ltd., Sichuan, China 200901CMT-7
ChuanmutongWusheng Pharmaceutical Group Co., Ltd., Sichuan, China 201201CMT-8
ChuanmutongLimin Chinese Herbal Pieces Co., Ltd., Sichuan, China 201001CMT-9
ChuanmutongYuhetang Pharmaceutical Co., Ltd., Sichuan, China210501CMT-10
Clematis argentilucida (Levl. et Vant.) W. T. WangMadzi Bridge, Sanlang Township, Tianquan County, Sichuan, China -CC
Clematis apiifolia var. obtusidentata Rehd. et Wils.Heilin Village, Qiliping Township, Hongya County, Sichuan, China -DC
Clematis peterae Hand.-Mazz.Huangmu Village, Huangmu Township, Hanyuan County, Sichuan, China -DE
Clematis gouriana Roxb. Var. finetii Rehd. et WilsMixedang Mountain, Huangwan Township, Emei County, Sichuan, China -XS
Clematis finetiana Levl. et Vaniot.Wannian Village, Huangwan Township, Emei County, Sichuan, China -SMT
Electronic balanceHaozhuang Hengping Scientific Instrument Co., Ltd., Shanghai,  China FA1204
ErgosterolMeisai Biological Technology Co., Ltd, Chongqing, China20210201
EthanolKelon Chemical Co., Ltd., Chengdu, China2021112602
Ethyl acetateZhiyuan Chemical Reagent Co., Ltd., Tianjin, China2017042043
Formic acidKelon Chemical Co., Ltd., Chengdu, China2016062901
High performance liquid chromatographyAgilent, USA.1260
IBM SPSS Statistics version 26.0International Business Machines Corporation, USA-
MethanolSigma-Aldrich  Trading Co., Ltd., Shanghai, ChinaWXBD6409V
MethanolKelon Chemical Co., Ltd., Chengdu, China202010302
n-butyl alcoholZhiyuan Chemical Reagent Co., Ltd., Tianjin, China2020071047
Petroleum etherZhiyuan Chemical Reagent Co., Ltd., Tianjin, China2020090125
Phosphoric acidComeo Chemical Reagent Co., Ltd., Tianjin, China20200110
SESCF-TCM version 2012National Pharmacopoeia Commission, China-http://114.247.108.158:8888/login
StigmasterolMeisai Biological Technology Co., Ltd., Chongqing, China20210201
TrichloromethaneSinopharm Group Chemical Reagent Co., Ltd., Shanghai, China20200214
Umetrics SIMCA version 14.1.0.2047Umetrics, Sweden-https://www.sartorius.com/en/products/process-analytical-technology/data-analytics-software/mvda-software/simca/simca-free-trial-download
Ultrapure water machineYoupu Ultrapure Technology Co., Ltd., Sichuan, ChinaUPH-II-10T
Ultrasonic cleanerKunshan Hechuang Ultrasound Instrument Co., Ltd., Jiangsu, ChinaKH3200E

References

  1. Chen, C. R. . Chinese Medicine Specimen Picture Book. , 116 (1935).
  2. Xiong, J., et al. Lignans from the stems of Clematis armandii ("Chuan-Mu-Tong") and their anti-neuroinflammatory activities. Journal of Ethnopharmacology. 153 (3), 737-743 (2014).
  3. Pan, L. L., et al. a lignan from the Chinese medicinal plant Clematis armandii, inhibits A431 cell growth via blocking p70S6/S6 kinase pathway. Integrative Cancer Therapies. 16 (3), 351-359 (2017).
  4. Chinese Pharmacopoeia Commission. . Pharmacopoeia of The People's Republic of China: (Edition 2020). , 38 (2020).
  5. Wang, D. G., Guo, J. L. Textual research on the materia medica and authenticity of Clematidis armandii. Lishizhen Medicine and Materia Medicine Research. 18 (11), 2696 (2007).
  6. Fang, Q. M., Zhang, M., Zhong, Y. Y. The natural resources and exploitation of Caulis Clematidis Armandii in Sichuan. West China Journal of Pharmaceutical Sciences. 20 (5), 404-406 (2005).
  7. Bai, M. N., Dai, Y. X., Wang, Y., Ren, Y. Y., Tan, R. Study on the identification of Caulis Clematidis Armandii. Research and Practice on Chinese Medicines. 31 (3), 13-16 (2017).
  8. Zhou, P. J., Li, X. F., Fu, D. H., Pu, X. Y., Zhu, G. Q. Pharmacognosy identification of Ethnomedicine Clematis ranunculoides Franchet. Journal of Guangzhou University of Traditional Chinese Medicine. 34 (3), 432-436 (2017).
  9. Guo, J. L., Tang, Y., Pei, J., Wang, D. G. Study on random amplified polymorphic DNA and sequence characterized amplified regions of Caulis Clematidis Armandii. Journal of Chengdu Medical College. 6 (4), 283-286 (2011).
  10. Liu, M. Z., Li, M. N., Yao, H., Liu, P. Molecular identification of Clematidis Armandii Caulis and its adulterants and closely related species by ITS2 sequence. Global Traditional Chinese Medicine. 4 (6), 446-450 (2011).
  11. Liu, J. J., Chen, X., Wei, Z. Q., Li, B. Chemical constituents and identification of the caules of Clematis armandii Franch.and Clematis montana Buch.-Ham. Natural Product Research and Development. 22 (6), 998-1000 (2010).
  12. Yang, T. R., Xu, Z., Shi, Y. N. Studies on four compounds from Clematis Montana. Journal of Liaoning University of Traditional Chinese Medicine. 10 (4), 142-143 (2008).
  13. Yan, L. H., Xu, L. Z., Zhou, Z. M., Yang, S. L. Chemical constituents from stems of Clematis armandii(I). Chinese Traditional and Herbal Drugs. 38 (3), 340-342 (2007).
  14. Li, X., et al. Traditional uses, phytochemistry, pharmacology, and toxicology of Akebiae Caulis and its synonyms: A review. Journal of Ethnopharmacology. 277, 114245 (2021).
  15. Ye, X., et al. Diuretic effect and material basis of Clematidis Armandii Caulis in rats. China Journal of Chinese Materia Medica. 44 (9), 1889-1894 (2019).
  16. Kuang, Y., et al. Consistency study of Caulis Clematidis Armandii and its traditionally used products and counterfeit species based on efficacy and pharmacognosy. Pharmacology and Clinics of Chinese Materia Medica. 36 (3), 115-121 (2020).
  17. Li, Y., et al. Quality assessment of Asarum heterotropoides var. mandshuricum based on HPLC multi-component determination and multiple pattern recognition method of fingerprint. Chinese Traditional and Herbal Drugs. 53 (1), 238-243 (2022).
  18. Li, Y., et al. Determination of multi-components of Paeoniae Alba Radix based on fingerprints and chemical pattern recognition. Chinese Traditional and Herbal Drugs. 53 (1), 231-237 (2022).
  19. Li, H. H., et al. Comparative investigation for raw and processed products of Euodiae Fructus based on high-performance liquid chromatography fingerprints and chemical pattern recognition. Chemistry & Biodiversity. 18 (8), 2100281 (2021).
  20. Dong, L. J., et al. Study on suitable distribution areas of Kawa Kimichi produced in Sichuan province-based on remote sensing and GIS-A case study of Clematis Armandii. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology. 17 (11), 2398-2404 (2015).
  21. Tang, S. W., Pei, J., Li, F. Y. Morphological and histological identification of Chuanmutong. West China Journal of Pharmaceutical Sciences. 15 (1), 19-21 (2000).
  22. Li, B., Chen, X., Fang, Q. M., Zhang, B. J., Wei, Z. Q. Quality Research of Chuanmutong. Journal of Sichuan of Traditional Chinese Medicine. 27 (6), 58-60 (2009).
  23. Wu, W. J., Wan, M. M., Cao, Y. H., Tan, R., Song, L. K. Research on the Quality Standard of Chuanmutong. Chinese Archives of Traditional Chinese Medicine. 33 (2), 313-315 (2015).
  24. Wei, Z. Q., Chen, X., Li, B., Dong, X. P. Determination of stigmasterol in Clematis armandii Franch and Clematis montana Buch-Ham. by HPLC. Lishizhen Medicine and Materia Medica Research. 20 (3), 574-575 (2009).
  25. Qing, L. S., et al. Determination of oleanolic acid in Caulis clematidis armandii by HPLC. West China Journal of Pharmaceutical Sciences. 21 (3), 273-274 (2006).
  26. Yang, S. D., Wang, R., Fu, D. Y., Guo, J. J., Tan, W. Y. Determination on oleanolic acid in caulis clematidis armandii by microwave assisted extraction-HPLC/MS. Anhui Academy of Agricultural Sciences. 38 (13), 6929-6931 (2010).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

HPLCChemical FingerprintingClematidis Armandii CaulisAuthenticity IdentificationMedicinal Material QualitySample PreparationChromatographic FingerprintsSimilarity Evaluation SystemTCM AnalysisAdulterants DetectionMobile Phases PreparationStability Evaluation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved